CDC

Global Weight Loss Drugs Markets Report 2023-2024 & 2029 - The Emergence of GLP-1 and GIP, Unmet Market Needs and Emerging Product Pipeline - ResearchAndMarkets.com

Retrieved on: 
금요일, 4월 26, 2024
Health, Fitness & Nutrition, Other Science, General Health, Science, Pharmaceutical, Biotechnology, Online, Conditional sentence, Market, Semaglutide, Sale, Investment, Social media, Injection, Weight gain, Huadong Medicine, Safety, Risk, Plasma protein binding, CDC, Underweight, Alli, OTC, Overweight, Eli Lilly, GSK plc, Diabetes, Weight loss, Research, Liraglutide, USFDA, Appetite, Success, Roche, Obesity, Culture, Novo Nordisk, Distribution, Patient, Powder, Metabolism, Marketing, GIP, Cancer, COVID-19, Pharmacy, Growth, Prevalence, Pharmaceutical industry

The global weight loss drugs market was valued at US$3.83 billion in 2023, and is expected to be worth US$44.12 billion in 2029.

Key Points: 
  • The global weight loss drugs market was valued at US$3.83 billion in 2023, and is expected to be worth US$44.12 billion in 2029.
  • The global weight loss drugs market is expected to grow at a CAGR of 49.85% over the years 2024-2029.
  • The weight loss drugs market in the Asia Pacific is expected to grow significantly during the forecasted period.
  • Offline distribution channels, comprising brick-and-mortar pharmacies, clinics, and healthcare facilities, dominated the global weight loss drugs market in 2023.

Clinical Trial by Harvard Pilgrim Health Care Institute, HCA Healthcare, UCI Health and CDC Identifies Strategy to Rapidly Detect and Respond to Hospital Outbreaks Using Algorithm-Driven Technology

Retrieved on: 
화요일, 4월 23, 2024
Data Management, Other Health, Technology, Managed Care, General Health, Infectious Diseases, Hospitals, Clinical Trials, Other Technology, Biotechnology, Science, Software, Networks, Other Science, Research, Health, University, Hospital, Risk, CDC, University of California, HCA Healthcare, Patient safety, Fungal infection, Doctor of Science, Patient, MPH, UCI, NEJM, Harvard Medical School, Infection, Harvard Pilgrim Health Care, Doctor of Public Health, Senior advisor, COVID-19, CLUSTER, Vaccine

The large multi-state, real-world study was conducted in 82 hospitals and led by Harvard Pilgrim Health Care Institute, HCA Healthcare, University of California, Irvine (UCI) Health and the Centers for Disease Control and Prevention (CDC).

Key Points: 
  • The large multi-state, real-world study was conducted in 82 hospitals and led by Harvard Pilgrim Health Care Institute, HCA Healthcare, University of California, Irvine (UCI) Health and the Centers for Disease Control and Prevention (CDC).
  • While hospitals and health systems work to prevent infections and reduce the opportunity for outbreaks to occur, there is no standardized approach for detecting transmission.
  • Early detection can lead to a rapid response that reduces the chance for outbreaks to occur.
  • “The CLUSTER trial provides evidence that early detection powered by automation tools and quick action can prevent outbreaks from growing."

Two Clinical Trials Identify a Better Way to Target Appropriate Antibiotics for Patients Hospitalized With Pneumonia or Urinary Tract Infection

Retrieved on: 
금요일, 4월 19, 2024
Research, Infectious Diseases, Hospitals, Clinical Trials, Other Health, Health, Pharmaceutical, General Health, Science, Epidemiology, UTI, Infection, Physician, Harvard University, University, Urinary tract infection, JAMA, Pneumonia, Risk, Hospital, CDC, Bacteria, American Medical Association, Health care, INSPIRE, HCA Healthcare, Workflow, Patient, COVID-19, MPH, UCI, Fungus, Assistant, Harvard Pilgrim Health Care, Harvard Medical School, Journal, Division, Pharmaceutical industry

The two newly published studies, the INSPIRE Pneumonia and UTI Trials, involved more than 220,000 patients with pneumonia or UTI in 59 HCA Healthcare hospitals.

Key Points: 
  • The two newly published studies, the INSPIRE Pneumonia and UTI Trials, involved more than 220,000 patients with pneumonia or UTI in 59 HCA Healthcare hospitals.
  • This resulted in a better match for 28% of pneumonia patients and 17% of patients with UTI when compared to hospitals where physicians were not provided with alerts according to the trials.
  • The INSPIRE trials identified patients with low risk for antibiotic resistance and prompted physicians to order standard-spectrum antibiotics if extended-spectrum antibiotics were being ordered.
  • Additional information about the INSPIRE Pneumonia and UTI Trials can be found in the following JAMA author interview podcast.

Executive War College to Address, Clinical Laboratories’ and Genetic Testing Firms’ Perfect Storm, involving FDA’s Proposed LDT Rule, Payers Requiring Z-Codes on Genetic Test Claims, and Revisions to CLIA Regulations

Retrieved on: 
금요일, 4월 19, 2024
FDA, Health Technology, Publishing, Healthcare Reform, Communications, General Health, Medical Devices, Public Policy, Government, Genetics, Clinical Trials, Science, Biotechnology, Other Science, Health, Research, Dark, Storm, Organization, COLA, Leica Biosystems, Laboratory, Food, CDC, Cleveland Clinic, DLS, MD, Clinical Laboratory, Doctor of Philosophy, ISO, Pathology, Artificial intelligence, History, Genetic testing, ARUP Laboratories, CLIA, Marie Cassidy, Medical device, College, Multimedia, French Quarter, Division, IVD, Darkness

One is the Food and Drug Administration’s (FDA) proposed rule https://www.fda.gov/news-events/press-announcements/fda-proposes-rule-ai... to regulate laboratory developed tests (LDTs).

Key Points: 

US Counter Mounted Automatic Soap Dispenser Insights Report 2024: A $330 Million Market by 2029 with Bobrick, Bradley, Euronics, FontanaShowers, GOJO, KC, Sloan Valve, & Stern Engineering Dominating - ResearchAndMarkets.com

Retrieved on: 
월요일, 4월 15, 2024
Health, Manufacturing, Commercial Building & Real Estate, Construction & Property, General Health, Other Manufacturing, USD, Sloan Valve Company, Education, System, Hospital, PIR, CDC, Bacteria, Tourism, Gojo Industries, Foot, Kimberly-Clark, Virus, Fungus, Infection, Travel, Prevalence

Counter Mounted Automatic Soap Dispenser Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • Counter Mounted Automatic Soap Dispenser Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering.
  • The U.S. counter-mounted automatic soap dispenser market report includes exclusive data on 27 vendors.
  • The U.S. counter-mounted automatic soap dispenser market is characterized by the presence of a niche among established players.
  • The open refill method segment is leading the segment share in the U.S. counter-mounted automatic soap dispenser market.

Seismic Therapeutic Presents Preclinical Data on S-1117, its Novel Pan-IgG Protease Addressing Multiple Pathogenic Mechanisms in Autoimmune Disease, at American Academy of Neurology (AAN) 2024

Retrieved on: 
금요일, 4월 12, 2024
Health, Clinical Trials, Research, Pharmaceutical, Science, Biotechnology, American Academy, Immunoglobulin G, BCR, Tissue, Proteinuria, CDC, Novel, Myasthenia gravis, Doctor of Philosophy, Pharmacology, ADCC, Patient, Blood urea nitrogen, AAN, Polypharmacology, Autoimmunity, Vaccine

Seismic Therapeutic, Inc ., the machine learning immunology company, today announced the presentation of preclinical data for its pan‑immunoglobulin G (IgG) sculpting enzyme candidate, S-1117, at the American Academy of Neurology (AAN) 2024 annual meeting in Denver.

Key Points: 
  • Seismic Therapeutic, Inc ., the machine learning immunology company, today announced the presentation of preclinical data for its pan‑immunoglobulin G (IgG) sculpting enzyme candidate, S-1117, at the American Academy of Neurology (AAN) 2024 annual meeting in Denver.
  • The poster presentation titled, “Preclinical Pharmacology of S-1117, a Novel Engineered Fc-fused IgG Cleaving Enzyme, for Chronic Treatment of Autoantibody-mediated Diseases,” features preclinical in vitro and in vivo results supporting the differentiated therapeutic profile of S-1117.
  • S-1117 reduced IgG effector functions, significantly reducing antibody-dependent cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC) of peripheral blood mononuclear cells (PBMCs).
  • A murine nephritis model showed reduced complement and immune complex deposition, as well as reduced proteinuria, blood urea nitrogen and renal pathology.

UnitedHealthcare Provides $180,000 Investment to United Disabilities Services Foundation to Support Aging and Disability Services in Pennsylvania

Retrieved on: 
수요일, 4월 10, 2024
Mental Health, People with Disabilities, Pets, Health Insurance, Other Health, Managed Care, Health, Consumer, General Health, Volunteering, Dog, Hospital, Spectrum, Disability, CDC, PTSD, Diabetes, Medicaid, Resource, Depression, Obesity, Exercise, Physician, Medicare, Adapted automobile, Ageing, UnitedHealth Group

UnitedHealthcare Community Plan of Pennsylvania has provided a $180,000 investment to the United Disabilities Services Foundation (UDSF) to support aging and disability services for adults across the state.

Key Points: 
  • UnitedHealthcare Community Plan of Pennsylvania has provided a $180,000 investment to the United Disabilities Services Foundation (UDSF) to support aging and disability services for adults across the state.
  • The nonprofit offers programs and resources to support people who are living with disabilities, aging or are recovering from an injury.
  • “UnitedHealthcare Community Plan of Pennsylvania is dedicated to helping people live healthier lives and is an organization that can be trusted to do what they say,” said William Kepner, CEO, United Disabilities Services Foundation.
  • They truly walk the talk and are great collaborative partners.”
    In Pennsylvania, 1 in 4 adults — nearly 26% — have a disability.

QuidelOrtho Adds Fentanyl Test to Its Vitros® Systems as a MicroTip® Partnership Assay

Retrieved on: 
수요일, 4월 10, 2024
Science, Biotechnology, Research, Pharmaceutical, Medical Supplies, Health, Medical Devices, Hospitals, Urine, Addiction, Mortality, University, Fentanyl, Risk, Hospital, CDC, 7600, UMD, XT, Substance Abuse, Fatality, Medicine, Multimedia, Maryland School, Assistant, QuidelOrtho, Pharmaceutical industry

QuidelOrtho Corporation (Nasdaq: QDEL) has added the ARK™ Fentanyl II Assay to its U.S. Vitros® XT 7600 and 5600 Integrated Systems as well as its Vitros® 4600 Chemistry System menu of assays as a MicroTip® Partnership Assay (“MPA”).

Key Points: 
  • QuidelOrtho Corporation (Nasdaq: QDEL) has added the ARK™ Fentanyl II Assay to its U.S. Vitros® XT 7600 and 5600 Integrated Systems as well as its Vitros® 4600 Chemistry System menu of assays as a MicroTip® Partnership Assay (“MPA”).
  • This Fentanyl assay will help hospital and emergency room customers respond to the critical demand for enhanced opioid testing, allowing on-site fentanyl testing in less than 10 minutes to aid in immediate clinical decisions.
  • As part of QuidelOrtho’s Vitros systems’ menu of assays, the test offers clinical fentanyl testing for hospitals and emergency departments, providing an effective approach to preliminary urine drug testing.
  • When patients test positive for opioids on a standard drug test, they’re usually directed to drug treatment programs.

Mental Health Awareness Month in May to Highlight Initiatives to Help Prevent Suicide in Illinois

Retrieved on: 
금요일, 4월 26, 2024
Dark, Education, Volunteering, AFSP, Veteran, Genetics, Hope, Risk, Mental Health Awareness Month, CST, CDC, Death, Trauma, Love, Thought, Research, Suicide, HOW, Accident, Life, Grammatical mood, Female, Embarrassment, Week, Mental health, Firearm, Behavior, Abuse, Save, Organization, Darkness, Nursing

CHICAGO, April 26, 2024 /PRNewswire/ -- Efforts are underway to reach more people with suicide prevention information and interventions across Illinois during Mental Health Awareness Month in May. The Illinois chapter of the American Foundation for Suicide Prevention (AFSP) is hosting numerous free prevention programs throughout the month.

Key Points: 
  • CHICAGO, April 26, 2024 /PRNewswire/ -- Efforts are underway to reach more people with suicide prevention information and interventions across Illinois during Mental Health Awareness Month in May.
  • The Illinois chapter of the American Foundation for Suicide Prevention (AFSP) is hosting numerous free prevention programs throughout the month.
  • Learn more about the American Foundation for Suicide Prevention - Illinois Chapter and the 2024 Out of the Darkness Chicagoland Walk.
  • If you or someone you know is at risk of suicide, please call or text 988 for the Suicide Crisis Lifeline.

Global Urine Output Monitoring Systems Market is Projected to Grow at a CAGR of ~5% by 2030 | DelveInsight

Retrieved on: 
목요일, 4월 25, 2024
Sentinel, Conditional sentence, FDA, Kidney, Nursing care plan, Urinary tract infection, Risk, Prevalence, CDC, 3i, Diabetes, Machine learning, Artificial intelligence, Intensive care unit, Urine, Patient safety, CKD, Dehydration, Patient, Operating, LAS, Data collection, Data management, Health, System, Chronic kidney disease, Intensive care medicine, Algorithm, Overalls, CE marking, Medical device

LAS VEGAS, April 25, 2024 /PRNewswire/ -- DelveInsight's Urine Output Monitoring Systems Market Insights report provides the current and forecast market analysis, individual leading urine output monitoring systems companies' market shares, challenges, urine output monitoring systems market drivers, barriers, trends, and key market urine output monitoring systems companies in the market.

Key Points: 
  • LAS VEGAS, April 25, 2024 /PRNewswire/ -- DelveInsight's Urine Output Monitoring Systems Market Insights report provides the current and forecast market analysis, individual leading urine output monitoring systems companies' market shares, challenges, urine output monitoring systems market drivers, barriers, trends, and key market urine output monitoring systems companies in the market.
  • Notable urine output monitoring systems companies such as BD, Potrero Medical Inc., 3i Group plc, Serenno Medical, RenalSense Ltd., FIZE Medical, and several others, are currently operating in the urine output monitoring systems market.
  • To read more about the latest highlights related to the urine output monitoring systems market, get a snapshot of the key highlights entailed in the Global Urine Output Monitoring Systems Market Report
    Urine output monitoring systems play a crucial role in healthcare settings, offering real-time insights into a patient's renal function and overall health status.
  • To know more about why North America is leading the market growth in the urine output monitoring systems market, get a snapshot of the Urine Output Monitoring Systems Market Outlook
    The urine output monitoring systems market dynamics are witnessing significant evolution driven by several factors.